Dr Chau holds the position of Consultant Medical Oncologist within the Gastrointestinal and Lymphoma Units at the Royal Marsden Hospital and Honorary Senior Lecturer at the Institute of Cancer Research, London & Surrey. He qualified from the United Medical & Dental Schools of Guy’s and St. Thomas’ Hospitals, University of London, before undergoing medical oncology specialist training and clinical research fellowship at the Royal Marsden Hospital.
His main research interests are clinical trials and translational research in gastrointestinal cancers and lymphoma. He is the chief or principal investigator of multiple phase I, II and III clinical trials evaluating novel treatment strategies and agents in various cancer signalling pathways.
Dr Chau serves or has served on the American Society of Clinical Oncology (ASCO) Scientific Program Committee, ASCO Education Committee, European Society of Medical Oncology (ESMO) Congress Steering Committee, ESMO Asia Scientific Programme and Steering Committee, ESMO Educational Committee and UK National Cancer Research Institute (NCRI) Colorectal Cancer and Pancreatic Cancer Clinical Study Groups. He is on the Trial Management Groups and Trial Steering Groups of multiple national and global phase II-III gastrointestinal cancer and lymphoma trials. He serves or has served on the UK National Institute of Health and Care Excellence (NICE) Clinical Guideline Development Group for non-Hodgkin’s Lymphoma and ASCO Management of Immune-mediated side effects Guideline Panel. He is the recipient of the Swedish Society of GI Oncology Bengt Glimelius Award 2016, merit awards from ASCO Gastrointestinal Cancer Symposium, The Royal Society of Medicine Section of Oncology Clinical Prize, fellowships from the European School of Oncology and ASCO / American Association for Cancer Research (AACR) / Federation of European Cancer Societies (FECS) Clinical Cancer Research Workshop.